Dalhousie University
Group A Streptococcus vaccine efficacious in healthy adults
Published in Law and Health Weekly, December 3rd, 2005
According to recent research from Canada and the United States, "Group A streptococcus (GAS) causes illness ranging from uncomplicated pharyngitis to life-threatening necrotizing fasciitis, toxic shock, and rheumatic fever. Attempts to develop an M protein-based vaccine have been hindered by the fact that some M proteins elicit both protective antibodies and antibodies that cross-react with human tissues."
"New molecular techniques have allowed the previous obstacles to be largely overcome. The vaccine is comprised of four recombinant proteins...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Cardinal Health, Inc.
Ivan K. Fong named chief legal officer at pharmaceutical, medical supply company - Center for Information & Study on Clinical Resea
Media coverage of prescription drug safety deters clinical trial participation - Dynavax Technologies Corp.
Nancy L. Buc, former U.S. FDA chief counsel, joins board of directors - Finance
Home health company reports 2.2% decrease in revenue - Florida State University
Florida researcher's device grows quantities of adult stem cells for research - Greatbatch, Inc.
Component maker enters into a tantalum capacitor license agreement with Medtronic - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
